Want to join the conversation?
Specialty pharmaceutical company $VRX said the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the US FDA has voted by 18 to 0 to brodalumab injection, 210 mg, for adult patients with moderate-to-severe plaque psoriasis. FDA will consider this recommendation in its review of the Biologics License Applications for brodalumab.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.